Life Sciences Law360 provides breaking legal news and analysis on the
pharmaceutical and medical device industry. Coverage includes high-stakes
litigation and policy developments that affect life sciences companies, as well
as licensing deals, mergers, and other corporate transactions.
Sign up for a 7-day FREE trial today!
Latest News in Life Sciences
-
June 10, 2026
Medical device maker DexCom Inc. has urged a New York federal judge to toss a proposed investor class action over the reliability of the company's glucose monitoring device, arguing the suit is an attempt to recast good-faith business "as fraud based on routine disagreement between a medical device company and its regulator."
-
June 10, 2026
An investor of rare disease treatment company Catalyst Pharmaceuticals Inc. is attempting to stop a buyout by Italian rival Angelini Pharma SpA, saying Catalyst's deficient proxy statement omits relevant information regarding potential conflicts in the proposed transaction.
-
June 10, 2026
The U.S. Food and Drug Administration can't stop companies from selling ZEO Universe synthetic nicotine pouches, a Florida federal court has ruled, saying the agency likely acted illegally when it imposed costly new testing requirements without analyzing their economic effect on small businesses.
-
June 10, 2026
The Patent Trial and Appeal Board has invalidated the entirety of an Inari Medical Inc. patent covering the company's thrombectomy products, in a challenge brought by Imperative Care Inc.
-
June 10, 2026
Greenberg Traurig LLP announced Wednesday that it had brought on two veteran litigators from Goodwin Procter LLP to its New York office, bolstering its intellectual property litigation practice as the law evolves to keep pace with ever-changing technological innovations.
See more Life Sciences news